Tarsons Products Hits New 52-Week Low at Rs. 279.05

Tarsons Products, a small-cap player in the healthcare services sector, has reached a new 52-week low of Rs. 279.05 on November 7, 2025. This decline marks a significant downturn for the stock, which has underperformed its sector by 0.9% today and has seen a consecutive fall over the past five days, resulting in a total drop of 3.66% during this period. The stock's performance over the past year has been notably poor, with a decline of 35.67%, contrasting sharply with the Sensex, which has gained 4.02% in the same timeframe. Tarsons Products is currently trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a persistent downward trend. Financial metrics reveal challenges for the company, including a low Return on Capital Employed (ROCE) of 8.12%, reflecting limited profitability per unit of capital. Additionally, the company has experienced a significant drop in operating profit growth, averaging -18.84% annually over the last five years. Institutional investor participation has also waned, with a 3.27% decrease in stake over the last quarter.